Table 1.
Patient Characteristics
| All Patients (N=44) | |
|---|---|
| Number of biopsies reviewed/patient n(%) | |
| 1 | 28 (63.6%) |
| 2 | 11 (25.0%) |
| 3 | 3 (6.8%) |
| 4 | 2 (4.5%) |
| Age at transplantation years median (IQR) | 47(35-54) |
| Years from transplantation to biopsy median (IQR) | 1.0 (0.6-2.1) |
| Female gender n(%) | 30 (68.2%) |
| Race n(%) | |
| Caucasian | 40 (90.9%) |
| Hispanic | 2 (4.5%) |
| African American | 1 (2.3%) |
| Pacific Islander | 1 (2.3%) |
| Donor Type n(%) | |
| Living unrelated donor | 25 (56.8%) |
| Living related donor | 17 (38.6%) |
| Deceased donor | 2 (4.5%) |
| Etiology of ESRD n(%) | |
| Glomerulonephritis | 19(43.2%) |
| Cystic Kidney Disease | 5(11.4%) |
| Diabetes Mellitus | 5(11.4%) |
| Hypertension | 4(9.1%) |
| Congenital Renal Disease | 2(4.5%) |
| Other | 7(15.9%) |
| Unknown | 2(4.5%) |
| Positive B-flow crossmatch n(%) | 36(81.8%) |
| Maintenance immunosuppression n(%) | |
| Tacrolimus, Mycophenolate mofetil, Prednisone | 42(95.4%) |
| Other | 2(4.5%) |
| Allograft status 2 years post transplant n(%) | |
| Active | 43 (97.7%) |
| Failure | 1 (2.3%) |
| Allograft status 5 years post transplant n(%) | |
| Active | 36 (81.8%) |
| Failure | 8 (18.2%) |